Literature DB >> 27271532

Differences in cardiovascular manifestations between ankylosing spondylitis patients with and without kyphosis.

Jun Fu1, Manyan Wu2, Yan Liang1, Kai Song1, Ming Ni1, Yonggang Zhang1, Jiying Chen3.   

Abstract

The objective of this study is to evaluate the differences in cardiovascular manifestations between ankylosing spondylitis (AS) patients with and without kyphosis. A retrospective review of consecutive AS patients treated at our hospital between June 2013 and June 2015 was performed. There were 122 patients who met all of the inclusion and exclusion criteria. Among these patients, there were 57 (ASK group) patients with global kyphosis (GK) > 40° and 65 (AS group) patients with GK < 40°. General information, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), electrocardiography, and echocardiography were record. ESR and CRP levels in the ASK group were significantly higher than the AS group (P < 0.05). Fifteen patients in ASK group but 3 patients in AS group suffered from a left ventricular high voltage (P < 0.05). Heart rate in ASK group was 83.91 ± 13.68 beats/min, and it was 73.88 ± 13.04 beats/min in AS group (P < 0.05). The E/A ratio was 1.13 ± 0.38 in ASK group and 1.32 ± 0.49 in AS group (P < 0.05). The mitral E-wave deceleration time and isovolumetric relaxation time were, respectively, 236.25 ± 34.26 ms and 101.86 ± 17.57 ms in ASK group, which were shorter in AS group (P < 0.05). This study showed that AS patients with kyphosis had a statistically increased incidence of cardiovascular complications including a more rapid heart rate, left ventricular high voltage, and left ventricular diastolic dysfunction.

Entities:  

Keywords:  Ankylosing spondylitis; Cardiovascular; Echocardiography; Electrocardiography

Mesh:

Substances:

Year:  2016        PMID: 27271532     DOI: 10.1007/s10067-016-3324-8

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  39 in total

1.  Pulmonary involvement in ankylosing spondylitis.

Authors:  Percival D Sampaio-Barros; Elza Maria F P Cerqueira; Sílvio M Rezende; Lucimara Maeda; Roseneide A Conde; Verônica A Zanardi; Manoel Barros Bértolo; José Ribeiro de Menezes Neto; Adil M Samara
Journal:  Clin Rheumatol       Date:  2006-03-30       Impact factor: 2.980

2.  Relationship of QT interval duration with carotid intima media thickness in a clinically healthy population undergoing cardiovascular risk screening.

Authors:  B Strohmer; M Pichler; B Iglseder; B Paulweber
Journal:  J Intern Med       Date:  2005-03       Impact factor: 8.989

3.  EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.

Authors:  M J L Peters; D P M Symmons; D McCarey; B A C Dijkmans; P Nicola; T K Kvien; I B McInnes; H Haentzschel; M A Gonzalez-Gay; S Provan; A Semb; P Sidiropoulos; G Kitas; Y M Smulders; M Soubrier; Z Szekanecz; N Sattar; M T Nurmohamed
Journal:  Ann Rheum Dis       Date:  2009-09-22       Impact factor: 19.103

4.  Cardiovascular manifestations of ankylosing spondylitis.

Authors:  T D Kinsella; L G Johnson; R Ian
Journal:  Can Med Assoc J       Date:  1974-12-21       Impact factor: 8.262

Review 5.  Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis.

Authors:  Mike J Peters; Irene E van der Horst-Bruinsma; Ben A Dijkmans; Michael T Nurmohamed
Journal:  Semin Arthritis Rheum       Date:  2004-12       Impact factor: 5.532

6.  Rib cage motion in ankylosing spondylitis patients: a pilot study.

Authors:  Maria Ragnarsdottir; Arni Jon Geirsson; Bjorn Gudbjornsson
Journal:  Spine J       Date:  2007-02-20       Impact factor: 4.166

7.  Ankylosing spondylitis: a risk factor for myocardial infarction?

Authors:  M J L Peters; I Visman; M M J Nielen; N Van Dillen; R A Verheij; I E van der Horst-Bruinsma; B A C Dijkmans; M T Nurmohamed
Journal:  Ann Rheum Dis       Date:  2009-04-28       Impact factor: 19.103

8.  Aortic root disease and valve disease associated with ankylosing spondylitis.

Authors:  C A Roldan; J Chavez; P W Wiest; C R Qualls; M H Crawford
Journal:  J Am Coll Cardiol       Date:  1998-11       Impact factor: 24.094

9.  Impact of age on the cardiovascular response to dynamic upright exercise in healthy men and women.

Authors:  J L Fleg; F O'Connor; G Gerstenblith; L C Becker; J Clulow; S P Schulman; E G Lakatta
Journal:  J Appl Physiol (1985)       Date:  1995-03

10.  Increased risk of ischemic heart disease in young patients with newly diagnosed ankylosing spondylitis--a population-based longitudinal follow-up study.

Authors:  Ya-Ping Huang; Yen-Ho Wang; Shin-Liang Pan
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

View more
  2 in total

1.  Quality of life and correlation with clinical and radiographic variables in patients with ankylosing spondylitis: a retrospective case series study.

Authors:  Ji-Chen Huang; Bang-Ping Qian; Yong Qiu; Bin Wang; Yang Yu; Ze-Zhang Zhu; Jun Hu; Zhe Qu
Journal:  BMC Musculoskelet Disord       Date:  2017-08-15       Impact factor: 2.362

2.  Prevalence and Risk for Bundle Branch Block, Atrioventricular Block and Pacemaker Implantation in Spondyloarthritis. A Systematic Review of the Literature.

Authors:  Hye Sang Park; Ana Laiz; Petra Díaz Del Campo; María A Martín Martínez; M Guerra-Rodriguez; Concepcion Alonso-Martin; Jesus Sanchez-Vega; Hector Corominas
Journal:  Front Med (Lausanne)       Date:  2022-03-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.